IIT-B Scientist Gets DCGI Nod To Launch Algorithm-based Covi
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
Bengaluru-based tech startup Algorithmic Biologics has received regulatory approvals to launch its Covid-19 testing method that can help scale up testing for the deadly virus infection at half the prevailing cost and one-tenth of the time. Called Tapestry, the new testing tool is developed by the startup launched by IIT-Bombay professor Manoj Gopalkrishnan.

It enables the safe reopening of places of work and education as it is affordable and can be used frequently using a single round quantitative pooling algorithm with the gold-standard RT-PCR test. Tapestry, which has been under development since last March, has just been cleared by the Drugs Controller General (DCGI) for commercial use as a non-regulated medical device and has also been registered with the Central Drugs Standard Control Organization.

Tapestry lowers testing time to four hours, which is just a tenth of the present time taken by the traditional RT-PCR tests, while the cost is under 50 percent of the lowest such test at around Rs 250, he said. The tool has undergone sampling tests on over 8,000 people since last July. Clinical trials were carried out at Tata Memorial Centre from last August, while field trials were held on the students of the International Institute of Information Technology in Hyderabad from this February, said Gopalkrishnan.

The tool works like a compression algorithm for molecular testing and uses samples from different individuals, which are mixed into pools using a code. Each sample is sent to three pools, ensuring testing in triplicate and accurate results. Individual-level results are recovered by looking at the pattern of the pooling results and applying a decoding algorithm, said the 40-year-old professor.

Dr. T●●●●z H●●●●●●i and 2 other likes this